http://hdl.handle.net/1765/20852
http://dx.doi.org/10.1111/j.1365-2141.2010.08240.x
scopus: 77955798380
http://dx.doi.org/10.1111/j.1365-2141.2010.08240.x
scopus: 77955798380
The potential use of basigin (CD147) as a prognostic marker in B-cell precursor acute lymphoblastic leukaemia
September 2010
Article
volume 150, issue 5 pp 624-626.
| Related Files |
|---|
|
Redirect to Publisher's version
(Publisher's version.url.txt, 50 bytes) |
Repository contains one additional file which is not publicly available
Keywords
- human
- letter
- priority journal
- quantitative analysis
- real time polymerase chain reaction
- cell migration
- protein expression
- protein function
- prognosis
- acute lymphoblastic leukemia
- minimal residual disease
- tumor marker
- flow cytometry
- messenger RNA
- gene rearrangement
- immunophenotyping
- cancer relapse
- cell proliferation
- gene expression profiling
- immunoglobulin
- Western blotting
- pre B lymphocyte
- B cell leukemia
- B cell precursor acute lymphoblastic leukemia
- CD147 antigen
- basigin (CD147)
- diagnosis-relapse
- extramedullary
- lymphocyte differentiation
- normal B cells
- paediatric acute lymphoblastic leukaemia